secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mountain Crest Acquisition Corp. V (MCAG)
CIK:        0001859035
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0001829126-23-003236
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mountain Crest V furnishes investor presentation for AUM deal; no new material info
--------------------------------------------------------------------------------

- SPAC entered business combination agreement with AUM Biosciences on Oct 19, 2022, amended multiple times through April 19, 2023.
- Exhibit 99.1 is a form investor presentation used for management meetings; no new specific financial data or guidance disclosed.
- Presentation includes standard forward-looking statements and risk factors typical for pre-clinical biotech SPAC deals.
- Holdco has filed an F-4 registration statement with SEC; stockholders urged to read proxy statement/prospectus when available.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859035/000182912623003236/0001829126-23-003236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859035/000182912623003236/mountaincrest5_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-23-003236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer